ADA2017 Archives -

Novo Nordisk hopes that new data supporting the cardiovascular and glycaemic safety of its Tresiba long-acting insulin will

Novo hopes data will boost new insulin in US and Germany

https://pharmaphorum.com/news/novo-hopes-new-data-will-boost-new-insulin-us-germany/

Companies awaiting CV outcomes trial, and court decision in patent case

Sanofi/Regeneron PCSK9 lowers cholesterol in diabetes patients

https://pharmaphorum.com/news/sanofiregeneron-pcsk9/

ADA says photo ban is to protect intellectual property.

ADA to re-evaluate tweet ban after backlash

https://pharmaphorum.com/news/ada-re-evaluate-tweet-ban-backlash/

Reforms could take away health insurance from 23 million, and deny insurance to those with pre-existing conditions, such as diabetes

Senate could back Trump health law by 4th July, despite warnings of patient impact

https://pharmaphorum.com/news/senate-approve-health-reforms-4th-july/

ADA2017